Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surgepays (NQ: SURG )

1.840 -0.010 (-0.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Surgepays

< Previous 1 2 3 4 5 6 Next >
12 Communication Services Stocks Moving In Thursday's Intraday Session
Via Benzinga
10 Short Squeeze Candidates To Watch This Week: Getty Images, PaxMedica And This Meme Stock Retailer
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
7 Reasons Why SurgePays Is Going To Surge
We give you seven reasons why SurgePays stock (SURG​​​​​​​) is an excellent bet for 2023... 
Via Talk Markets
Singing Machine, SurgePays And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common... 
Via Benzinga
SurgePays: This Technology And Telecommunications Company Is Ready To Put The Pedal To The Metal
Brian Cox, CEO of SurgePays, Inc. (NASDAQ: SURG) was recently interviewed by Benzinga. 
Via Benzinga
Bitcoin Holder MicroStrategy, SurgePays And 3 Other Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common... 
Via Benzinga
PaxMedica, SurgePays, Opal Fuels And More Short Squeeze Candidates That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. 
Via Benzinga
Getty Images, MoonLake And 3 Other Short Squeeze Candidates That May Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. 
Via Benzinga
SurgePays: This Company Is Turning Your Bodega Into A Tech Center
Brian Cox, Chairman and CEO of SurgePays, Inc. (NASDAQ: SURG) was a guest on Benzinga’s All Access on Nov 18, 2022. 
Via Benzinga
PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week
We're checking in on the top short squeeze stocks to watch this week as traders continue to have an interest in this part of the market! 
Via InvestorPlace
PaxMedica, Getty Images And 3 Short Squeeze Candidates That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. 
Via Benzinga
12 Communication Services Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
GETY, PEGY: The Top 5 Short Squeeze Stocks to Watch This Week
Short squeeze stocks are worth watching this week as speculative traders seek out the shares with the most potential to move! 
Via InvestorPlace
Getty Images, MicroStrategy And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. 
Via Benzinga
7 Nasdaq Stocks to Sell Pronto Before a Painful Downturn
Although innovation brings excitement to the table, they also bring risk, boding poorly for these Nasdaq stocks to sell now. 
Via InvestorPlace
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
12 Communication Services Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
This Company Is Working To Bring Connectivity To Millions Of Americans Through The Affordable Connectivity Program (ACP)
As daily life becomes more digitized, growing concerns over inequity caused by the digital divide demand practical solutions. People increasingly rely on digital connectivity for work, health,... 
Via Benzinga
7 Short-Squeeze Stocks to Sell Before Traders Cash Out
Simply put, the market no longer benefits growth-centric aspirational companies. 
Via InvestorPlace
7 Under-the-Radar Growth Stocks With 200% Growth Potential
Each of these seven under-the-radar growth stocks could at least triple in price, in a relatively short period of time. 
Via InvestorPlace
TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the... 
Via Benzinga
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week! 
Via InvestorPlace
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
Gainers ZW Data Action Tech (NASDAQ:CNET) shares increased by 16.7% to $1.12 during Thursday's pre-market session. The market value of their outstanding shares is at $40.1 million. 
Via Benzinga
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week! 
Via InvestorPlace
Grenwich LilfeSciences, Blue Apron And 3 More Short Squeeze Candidates That May Soar
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week
Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher. 
Via InvestorPlace
5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
Looking Into Surgepays's Return On Capital Employed
According to Benzinga Pro data, during Q2, Surgepays (NASDAQ:SURG) posted sales of $28.00 million. Earnings were up 28.36%, but Surgepays still reported an overall loss of $891 thousand. 
Via Benzinga
The Last Digital Frontier: How One Company Plans To Close A Digital Divide Through Services In Underserved Communities
To the casual eye, digital currency and on-line communications intertwine with all aspects of life: It plays a part in how we live our everyday lives. What is the digital divide? It can be defined as... 
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.